Short communication: CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41

AIDS Research and Human Retroviruses

Volumn 30, Issue 5, 2014, Pages 476-479

  Cummins, Nathan W ^a   Neuhaus, Jacqueline ^b   Sainski, Amy M ^c   Strausbauch, Michael A ^a   Wettstein, Peter J ^a   Lewin, Sharon R ^d,e,f   Plana, Montserrat ^g   Rizza, Stacey A ^a   Temesgen, Zelalem ^a   Touloumi, Giota ^h   Freiberg, Matthew ⁱ   Neaton, James ^b   Badley, Andrew D ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

^d MONASH UNIVERSITY   (Australia)

^e ALFRED HOSPITAL   (Australia)

^f BURNET INSTITUTE   (Australia)

^g UNIVERSITY OF BARCELONA   (Spain)

^h UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁱ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CASPASE; CASPASE 8P41; UNCLASSIFIED DRUG; CASP8 PROTEIN, HUMAN; CASPASE 8;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL LOSS; CONTROLLED STUDY; DISEASE COURSE; DNA DAMAGE; ENZYME SYNTHESIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEMORY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TREATMENT WITHDRAWAL; VIRUS LOAD; VIRUS REPLICATION; APOPTOSIS; FLOW CYTOMETRY; HIV INFECTIONS; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOPTOSIS; CASPASE 8; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 84899848259     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0243     Document Type: Article

References (21)

1. Baker JV, Peng G, Rapkin J, et al.: Poor initial CD4 + recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases. J Acquir Immune Defic Syndr 2008;48(5):541-546
2. Rodriguez B, Sethi AK, Cheruvu VK, et al.: Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 2006;296(12): 1498-1506
3. Mellors JW, Margolick JB, Phair JP, et al.: Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 cell count slope for progression to AIDS and death in untreated HIV-1 infection. JAMA 2007;297(21):2349-2350
4. Doyle T and Geretti AM: Low-level viraemia on HAART: significance and management. Curr Opin Infect Dis 2012; 25(1):17-25
5. De Maria A and Cossarizza A: CD4saurus Rex & HIVelociraptor vs. development of clinically useful immunological markers: A Jurassic tale of frozen evolution. J Transl Med 2011;9:93
6. Nie Z, Phenix BN, Lum JJ, et al.: HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation. Cell Death Differentiation 2002;9(11):1172-1184
7. Bren GD, Whitman J, Cummins N, et al.: Infected cell killing by HIV-1 protease promotes NF-kappaB dependent HIV-1 replication. PLoS One 2008;3(5):e2112
8. Taylor JA, Cummins NW, Bren GD, et al.: Casp8p41 expression in primary T cells induces a proinflammatory response. AIDS 2010;24(9):1251-1258
9. Sainski AM, Natesampillai S, Cummins NW, et al.: The HIV-1-specific protein Casp8p41 induces death of infected cells through Bax/Bak. J Virol 2011;85(16):7965-7975
10. Nie Z, Bren GD, Rizza SA, and Badley AD: HIV protease cleavage of procaspase 8 is necessary for death of HIVinfected cells. Open Virol J 2008;2:1-7
11. Natesampillai S, Nie Z, Cummins NW, et al.: Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cells. PLoS Pathog 2010;6(11): e1001213
12. Cummins NW, Jiang W, McGinty J, et al.: Intracellular Casp8p41 content is inversely associated with CD4 T cell count. J Infect Dis 2010;202(3):386-391
13. El-Sadr WM, Lundgren JD, Neaton JD, et al.: CD4 + count-guided interruption of antiretroviral treatment. N Engl J Med 2006;355(22):2283-2296
14. Nie Z, Bren GD, Vlahakis SR, et al.: Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo. J Virol 2007;81(13):6947-6956
15. Cummins NW and Badley AD: Mechanisms of HIVassociated lymphocyte apoptosis: 2010. Cell Death Dis 2010;1:e99
16. Fevrier M, Dorgham K, and Rebollo A: CD4 + T cell depletion in human immunodeficiency virus (HIV) infection: Role of apoptosis. Viruses 2011;3(5):586-612
17. Doitsh G, Cavrois M, Lassen KG, et al.: Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 2010;143(5):789-801
18. Cooper A, Garcia M, Petrovas C, Yamamoto T, Koup RA, and Nabel GJ: HIV-1 causes CD4 cell death through DNAdependent protein kinase during viral integration. Nature 2013;498(7454):376-379
19. Zeng M, Haase AT, and Schacker TW: Lymphoid tissue structure and HIV-1 infection: Life or death for T cells. Trends Immunol 2012;33(6):306-314
20. Marchetti G, Tincati C, and Silvestri G: Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev 2013;26(1):2-18
21. Haas A, Zimmermann K, and Oxenius A: Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection. J Virol 2011;85(23): 12102-12113.